Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of experimental intracranial human malignant glioma

Journal of Neuro-Oncology

Volumn 43, Issue 2, 1999, Pages 99-108

  Cirielli, Corrado ^a,b   Inyaku, Kyosuke ^a   Capogrossi, Maurizio C ^a,b   Yuan, Xuan ^c   Williams, Jeffery A ^c  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b Ist Dermopatico dell' Immacolata   (Italy)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenoviral gene transfer; Apoptosis; Experimental malignant gliomas; p53

Indexed keywords

PROTEIN P53;

ADENOVIRUS; AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; GLIOBLASTOMA; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SURVIVAL;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL DIVISION; GENES, P53; GLIOMA; HUMANS; MICE; MICE, NUDE; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032855038     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006289505801     Document Type: Article

References (48)

1. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16: 1405-1409, 1989
2. Sneed PK, Prados MD, McDermott MW, Larson DA, Malec MK, Lamborn KR, Davis RL, Weaver KA, Wara WM, Phillips TL et al.: Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery 36: 898-903; discussion 903-904, 1995
3. Alexander E 3rd, Loeffler JS: Radiosurgery for primary malignant brain tumors. Semin Surg Oncol 14: 43-52, 1998
4. Grossman SA, Wharam M, Sheidler V, Kleinberg L, Zeltzman M, Yue N, Piantadosi S: Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma (see comments). J Clin Oncol 15: 2596-2603, 1997
5. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS et al.: Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26: 239-244, 1993
6. Bashir R, Hochberg F, Oot R: Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields. Neurosurgery 23: 27-30, 1988
7. Hochberg FH, Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology 30: 907-911, 1980
8. Fueyo J, Gomez-Manzano C, Yung WK, Liu TJ, Alemany R, Bruner JM, Chintala SK, Rao JS, Levin VA, Kyritsis AP: Suppression of human glioma growth by adenovirus-mediated Rb gene transfer (see comments). Neurology 50: 1307-1315, 1998
9. Staba MJ, Mauceri HJ, Kufe DW, Hallahan DE, Weichselbaum RR: Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft (in process citation). Gene Ther 5: 293-300, 1998
10. Chintala SK, Fueyo J, Gomez-Manzano C, Venkaiah B, Bjerkvig R, Yung WK, Sawaya R, Kyritsis AP, Rao JS: Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro. Oncogene 15: 2049-2057, 1997
11. Yamanaka R, Tanaka R, Yoshida S, Saitoh T, Fujita K: Growth inhibition of human glioma cells modulated by retrovirus gene transfection with antisense IL-8. J Neurooncol 25: 59-65, 1995
12. Wakimoto H, Yoshida Y, Aoyagi M, Hirakawa K, Hamada H: Efficient retrovirus-mediated cytokine-gene transduction of primary-cultured human glioma cells for tumor vaccination therapy. Jpn J Cancer Res 88: 296-305, 1997
13. Ram Z, Culver KW, Oshiro EM, Viola JJ, DeVroom HL, Otto E, Long Z, Chiang Y, McGarrity GJ, Muul LM, Katz D, Blaese RM, Oldfield EH: Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells (see comments). Nat Med 3: 1354-1361, 1997
14. Ram Z, Walbridge S, Shawker T, Culver KW, Blaese RM, Oldfield EH: The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J Neurosurg 81: 256-260, 1994
15. Oldfield EH, Ram Z, Culver KW, Blaese RM, DeVroom HL, Anderson WF: Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 4: 39-69, 1993
16. Benedetti S, Di Meco F, Pollo B, Bruzzone MG, Cirenei N, Spreafico R, Solero CL, Broggi G, Di Donato S, Finocchiaro G: Gene transfer of suicide genes for the treatment of malignant gliomas: efficacy, limitations, and perspectives for a combined immunotherapy. Acta Neurochir Suppl 68: 100-104, 1997
17. Ito M, Kedes L: Two-step delivery of retroviruses to postmitotic, terminally differentiated cells. Hum Gene Ther 8: 57-63, 1997
18. Kramm CM, Sena-Esteves M, Barnett FH, Rainov NG, Schuback DE, Yu JS, Pechan PA, Paulus W, Chiocca EA, Breakefield XO: Gene therapy for brain tumors. Brain Pathol 5: 345-381, 1995
19. Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S, Agricola B, Byrne E, Raffeld M, Moen R et al.: Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 176: 1125-1135, 1992
20. Gomez-Manzano C, Fueyo J, Kyritsis AP, Steck PA, Roth JA, McDonnell TJ, Steck KD, Levin VA, Yung WK: Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res 56: 694-699, 1996
21. Asai A, Miyagi Y, Hashimoto H, Lee SH, Mishima K, Sugiyama A, Tanaka H, Mochizuki T, Yasuda T, Kuchino Y: Modulation of tumor immunogenicity of rat glioma cells by s-Myc expression: eradication of rat gliomas in vivo. Cell Growth Differ 5: 1153-1158, 1994
22. Badie B, Hunt K, Economou JS, Black KL: Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model. Neurosurgery 35: 910-915; discussion 915-916, 1994
23. Goodman JC, Trask TW, Chen SH, Woo SL, Grossman RG, Carey KD, Hubbard GB, Carrier DA, Rajagopalan S, Aguilar-Cordova E, Shine HD: Adneoviral-mediated thymindine kinase gene transfer into the primate brain followed by sytemic ganciclovir: pathologic, radiologic, and molecular studies. Hum Gene Ther 7: 1241-1250, 1996
24. Van Meir EG, Kikuchi T, Tada M, Li H, Diserens AC, Wojcik BE, Huang HJ, Friedmann T, de Tribolet N, Cavenee WK: Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 54: 649-652, 1994
25. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM: p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52: 674-679, 1992
26. Cajot JF, Anderson MJ, Lehman TA, Shapiro H, Briggs AA, Stanbridge EJ: Growth suppression mediated by transfection of p53 in Hut292DM human lung cancer cells expressing endogenous wild-type p53 protein. Cancer Res 52: 6956-6960, 1992
27. Badie B, Drazan KE, Kramar MH, Shaked A, Black KL: Adenovirus-mediated p53 gene delivery inhibits 9L glioma growth in rats. Neurol Res 17: 209-216, 1995
28. Ponten J, Macintyre EH: Long term culture of normal and neoplasic human glia. Acta Pathol Microbiol Scand 74: 465-486, 1968
29. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993
30. Brody SL, Crystal RG: Adenovirus-mediated in vivo gene transfer. Ann N Y Acad Sci 716: 90-101; discussion 101-103, 1994
31. Wills KN, Maneval DC, Menzel P, Harris MP, Sutjipto S, Vaillancourt MT, Huang WM, Johnson DE, Anderson SC, Wen SF et al.: Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum Gene Ther 5: 1079-1088, 1994
32. Riccioni T, Cirielli C, Wang X, Passaniti A, Capogrossi MC: Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo. Gene Ther 5: 747-754, 1998
33. Kremer EJ, Perricaudet M: Adenovirus and adenoassociated virus mediated gene transfer. Br Med Bull 51: 31-44, 1995
34. Graham FL, Prevec L: Methods for construction of adenovirus vectors. Mol Biotechnol 3: 207-220, 1995
35. Okajima T, Nakamura K, Zhang H, Ling N, Tanabe T, Yasuda T, Rosenfeld RG: Sensitive colorimetric bioassays for insulin-like growth factor (IGF) stimulation of cell proliferation and glucose consumption: use in studies of IGF analogs. Endocrinology 130: 2201-2212, 1992
36. Norušis MJ SPSS 6.1 Guide to Data Analysis, 1995. p xviii, 582. Englewood Cliffs, N.J., Prentice Hall
37. Vincent AJ, Vogels R, Someren GV, Esandi MC, Noteboom JL, Avezaat CJ, Vecht C, Bekkum DW, Valerio D, Bout A, Hoogerbrugge PM: Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors. Hum Gene Ther 7: 197-205, 1996
38. Dufour T, Quillien V, Heresbach N, Denais A, Ferry N, Guegan Y: Gene therapy of cerebral glioblastoma by adenovirus vector. Experimental model in the rat. Chirurgie 123: 168-174, 1998
39. Freytag SO, Rogulski KR, Paielli DL, Gilbert JD, Kim JH: A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy (see comments). Hum Gene Ther 9: 1323-1333, 1998
40. Perez-Cruet MJ, Trask TW, Chen SH, Goodman JC, Woo SL, Grossman RG, Shine HD: Adenovirus-mediated gene therapy of experimental gliomas. J Neurosci Res 39: 506-511, 1994
41. Chen SH, Shine HD, Goodman JC, Grossman RG, Woo SL: Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 91: 3054-3057, 1994
42. Tong X, Engehausen DG, Freund CT, Agoulnik I, Guo Z, Oehler MK, Kim TE, Hasenburg A, Contant CF, Woo SL, Kieback DG: The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoter. Anticancer Res 18: 719-725, 1998
43. Liu TJ, el-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, Clayman GL: Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res 55: 3117-3122, 1995
44. Yang C, Cirielli C, Capogrossi MC, Passaniti A: Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res 55: 4210-4213, 1995
45. Cirielli C, Riccioni T, Yang C, Pili R, Gloe T, Chang J, Inyaku K, Passaniti A, Capogrossi MC: Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo. Int J Cancer 63: 673-679, 1995
46. Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu TJ: In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 55: 1-6, 1995
47. Vincent AJ, Esandi MC, Avezaat CJ, Vecht CJ, Sillevis Smitt P, van Bekkum DW, Valerio D, Hoogerbrugge PM, Bout A: Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies. Neurosurgery 41: 442-451; discussion 451-452, 1997
48. Shine HD, Wyde PR, Aguilar-Cordova E, Chen SH, Woo SL, Grossman RG, Goodman JC: Neurotoxicity of intracerebral injection of a replication-defective adenoviral vector in a semipermissive species (cotton rat). Gene Ther 4: 275-279, 1997